Annual Meeting 2019 - The Stage IV Melanoma: What Biomarkers and Treatments Are Appropriate in the Frontline Setting?

Alexander Menzies, a Medical Oncologist and Associate Professor of Melanoma Medical Oncology at Melanoma Institute Australia (MIA), The University of Sydney, and Royal North Shore and Mater Hospitals discusses appropriate biomarkers and treatments for Stage IV Melanoma.